Tandem Diabetes Correlations

TNDM Stock

USD 20.25 0.37 1.79%

The current 90-days correlation between Tandem Diabetes Care and Inspire Medical Systems is 0.26 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tandem Diabetes moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tandem Diabetes Care moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Tandem Diabetes Correlation With Market

Modest diversification

The correlation between Tandem Diabetes Care and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Moving together with Tandem Stock

0.81	HOLX	Hologic	Pair Corr
0.89	INFU	InfuSystems Holdings	Pair Corr
0.69	SSKN	STRATA Skin Sciences Earnings Call Today	Pair Corr
0.79	CDIOW	Cardio Diagnostics	Pair Corr
0.63	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.75	ELEV	Elevation Oncology	Pair Corr
0.77	GPCR	Structure Therapeutics	Pair Corr
0.7	ZURA	Zura Bio Limited	Pair Corr
0.79	ZVSA	ZyVersa Therapeutics	Pair Corr
0.78	IMMX	Immix Biopharma	Pair Corr
0.79	IMRX	Immuneering Corp	Pair Corr
0.72	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.81	PMVP	Pmv Pharmaceuticals	Pair Corr
0.88	PYXS	Pyxis Oncology	Pair Corr
0.76	SCLX	Scilex Holding	Pair Corr
0.82	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.62	ATNF	180 Life Sciences	Pair Corr

Moving against Tandem Stock

0.94	OCX	OncoCyte Corp	Pair Corr
0.75	MNDR	Mobile health Network	Pair Corr
0.71	LUCD	Lucid Diagnostics	Pair Corr
0.63	GOSS	Gossamer Bio	Pair Corr
0.34	PAVM	PAVmed Inc	Pair Corr
0.61	NVCT	Nuvectis Pharma	Pair Corr

Related Correlations Analysis

	DXCM	INSP	SWAV	PEN	PODD	ABT	ALGN	SYK	ASXC
DXCM		0.43	0.0	0.36	0.85	0.3	0.53	0.75	0.0	DXCM
INSP	0.43		0.0	-0.34	0.29	-0.29	0.66	0.03	0.0	INSP
SWAV	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	SWAV
PEN	0.36	-0.34	0.0		0.38	0.79	-0.42	0.66	0.0	PEN
PODD	0.85	0.29	0.0	0.38		0.19	0.48	0.69	0.0	PODD
ABT	0.3	-0.29	0.0	0.79	0.19		-0.51	0.66	0.0	ABT
ALGN	0.53	0.66	0.0	-0.42	0.48	-0.51		0.15	0.0	ALGN
SYK	0.75	0.03	0.0	0.66	0.69	0.66	0.15		0.0	SYK
ASXC	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		ASXC
	DXCM	INSP	SWAV	PEN	PODD	ABT	ALGN	SYK	ASXC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PODD	+ 0.85	DXCM
ABT	+ 0.79	PEN
SYK	+ 0.75	DXCM
SYK	+ 0.69	PODD
ALGN	+ 0.66	INSP
SYK	+ 0.66	PEN

High negative correlations

ALGN	- 0.51	ABT
ALGN	- 0.42	PEN
PEN	- 0.34	INSP
ABT	- 0.29	INSP
ASXC	- 0.0	SYK
ASXC	- 0.0	ALGN

Risk-Adjusted Indicators

There is a big difference between Tandem Stock performing well and Tandem Diabetes Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tandem Diabetes' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DXCM	1.80	0.04	0.01	0.00	2.51	(1.81)	3.79	(3.22)	15.07
INSP	2.31	(0.08)	0.00	(0.14)	0.00	0.00	5.02	(5.62)	18.61
SWAV	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PEN	1.71	0.28	0.14	0.21	1.71	(2.05)	3.63	(3.49)	18.42
PODD	1.41	0.08	0.04	0.08	1.97	(1.39)	3.50	(3.03)	9.83
ABT	1.03	0.21	0.15	0.44	1.24	(1.02)	2.53	(1.91)	8.04
ALGN	1.73	(0.49)	0.00	4.51	0.00	0.00	2.54	(3.85)	11.48
SYK	1.02	0.03	0.04	0.01	1.22	(1.10)	2.25	(1.71)	6.96
ASXC	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Tandem Diabetes Corporate Management

Tom Fox	Chief Officer	Profile
Susan Morrison	Chief Admin. Officer	Profile
Mark Novara	Executive Officer	Profile
Ross Sylvia	VP Marketing	Profile
David Esq	Transitional Advisor	Profile
Jordan MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC